Skip to Content

Tag: Home Infusion


PromptCare: ‘Stay away from the fads’ 

Specialty Providers

PromptCare: ‘Stay away from the fads’ 

June 7, 2024Theresa Flaherty, Managing Editor

NEW PROVIDENCE, N.J. – PromptCare’s recent acquisition of New Orleans-based Coastal Infusion Services will give the provider a blueprint to add ambulatory infusion suites to its offerings, says CEO Paul Jardina.  While PromptCare, which offers home infusion, specialty pharmacy and complex respiratory services, has had a limited number of infusion suites for the past several years, it hasn’t been a focus, he said.  “We thought they had done a really good job...

Home Infusion, Mergers & Acquisitions (M&A), PromptCare


Read Full Articlered right arrow icon

Specialty Providers

PromptCare expands nat’l footprint 

May 7, 2024HME News Staff

NEW PROVIDENCE, N.J. - PromptCare, a provider of at-home and alternate-site infusion therapy, has announced that Coastal Infusion Services, which has a presence throughout the southern U.S., is now part of its family of companies.  Coastal Infusion Services also cares for patients at six state-of-the-art ambulatory infusion suites (AISs) strategically located throughout southern Louisiana.   “This is a unique opportunity to combine two organizations with deeply experienced...

Home Infusion, Mergers & Acquisitions (M&A), PromptCare


Read Full Articlered right arrow icon

Also Noted

Soleo Health named partner for new drug

May 7, 2024HME News Staff

FRISCO, Texas – Soleo Health has been named a limited distribution specialty pharmacy partner to dispense RYPLAZIM manufactured by Kedrion Biopharma. RYPLAZIM is the first and only U.S. Food & Drug Administration-approved treatment for supporting the approximately 500 people in the U.S. affected by plasminogen deficiency type 1 (PLGD-1).  "We take pride in being among the few selected specialty pharmacy providers administering RYPLAZIM to PLGD-1 patients,” said Drew Walk, CEO...

Home Infusion, Soleo Health


Read Full Articlered right arrow icon

Also Noted

Soleo Health opens location in Mississippi 

April 30, 2024HME News Staff

RIDGELAND, Miss. – Soleo Health, a national provider of complex specialty pharmacy services, has opened its latest pharmacy and ambulatory infusion center (AIC) in Ridgeland, Miss. Soleo Health Jackson offers a broad range of specialty pharmacy services and infusion therapies to patients requiring complex specialty biologic and infusion therapies across Mississippi, including those in Jackson, Tupelo, Hattiesburg and throughout the Gulf Coast. “Soleo Health identified an opportunity to...

Home Infusion, Soleo Health


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care details impact of cyberattack

April 26, 2024Theresa Flaherty, Managing Editor

BANNOCKBURN, Ill. – Option Care Health’s cash flow during the first quarter was negatively impacted by the Change Healthcare cyberattack, but the company has not changed its outlook for the full year, executives said on a recent earnings call.  From the date of the cyberattack on February 21 through the rest of the quarter, Option Care was unable to submit more than half its claims, said John Rademacher, president and CEO.   “This has resulted in a detrimental...

Cyberattack, Home Infusion, Option Care


Read Full Articlered right arrow icon

Also Noted

AIC adds new drugs 

March 25, 2024HME News Staff

DALLAS – AIC, a division of AIS Healthcare, now offers GLASSIA and ARALAST NP, manufactured by Takeda, for the treatment of adult patients with clinically evident emphysema due to severe hereditary deficiency of Alpha1-PI (alpha1-antitrypsin deficiency). The nationally accredited home infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or at an infusion suite setting. “We’re excited and proud to be able to...

AIC, Home Infusion


Read Full Articlered right arrow icon

Also Noted

Soleo Health turns 10

March 7, 2024HME News Staff

FRISCO, Texas – Soleo Health marked its 10th anniversary on Feb. 24. Led by CEO Drew Walk and COO Craig Vollmer, Soleo Health was founded on the commitment to simplify complex care for patients, and over the past decade, it has become one of the fastest-growing independent specialty pharmacies. Notably, the company has collaborated with more than 22,000 prescribers and delivered care to more than 100,000 patients. “Looking ahead, we remain dedicated to defining the unique requirements...

Home Infusion, Soleo Health, specialty pharmacy


Read Full Articlered right arrow icon

Also Noted

Dynamic Access launches brand for home infusion 

March 4, 2024HME News Staff

DALLAS – Dynamic Access, a provider of vascular access solutions, has launched a new affiliate brand, Dynamic Infusion, to provide home infusion nursing services for patients with chronic conditions such as autoimmune disorders, hemophilia, Crohn’s disease, rheumatoid arthritis, multiple sclerosis and more. The Dynamic Infusion brand will support the operations of two legacy companies, each with more than a decade of experience delivering home infusion nursing services to patients throughout...

Dynamic Access, Dynamic Infusion, Home Infusion


Read Full Articlered right arrow icon

Tim Hadley

Also Noted

Palmetto Infusion names president 

February 27, 2024HME News Staff

COLUMBIA, S.C. – Palmetto Infusion, a provider of ambulatory and home infusion in the Southeast, has appointed Tim Hadley as its new president in a strategic move to bolster the company’s commitment to patient care. “Tim’s wealth of experience and dedication to health care align seamlessly with our mission,” said CEO David Goodall. “As we focus on industry-wide impact and shaping the company’s direction, I am confident that Tim will play a crucial role in...

Home Infusion, Palmetto Infusion, Tim Hadley


Read Full Articlered right arrow icon

John Rademacher

Specialty Providers

Option Care delivers ‘strong results’

February 22, 2024HME News Staff

BANNOCKBURN, Ill. – Option Care Health reported revenue of $1.12 billion for the fourth quarter of 2023, an increase of 9.5% compared to the same quarter in 2022.  Revenue for the full year was $4.3 billion, up 9.1% compared to 2022. Gross profit for the quarter was $247.1 million and adjusted EBITDA was $111.6 million.  “The Option Care Health team delivered strong financial results in the fourth quarter and full year of 2023 and continued to execute on our commitment...

Home Infusion, John Rademacher, Option Care


Read Full Articlered right arrow icon